Oncternal Therapeutics (NASDAQ:ONCT) Coverage Initiated at S

Research analysts at StockNews.com initiated coverage on shares of Oncternal Therapeutics (NASDAQ:ONCT – Get Rating) in a report released on Monday. The firm set a “sell” rating on the stock. ONCT has been the subject of several other reports. Brookline Capital Acquisition reaffirmed a “hold” rating on shares of Oncternal Therapeutics in a research report […]

Related Keywords

San Diego , California , United States , Davidf Hale , Jamesb Breitmeyer , , Securities Exchange Commission , Virtu Financial , Prudential Financial Inc , Maxim Group , Waypoint Capital Advisors , Oncternal Therapeutics Inc , Mirabella Financial Services , Richmond Brothers Inc , Oncternal Therapeutics , Get Rating , Capital Acquisition , Capital Management , Exchange Commission , Financial Services , Capital Advisors , Oncternal Therapeutics Daily , Nasdaq Onct , Conct , Medical , Initiated Coverage , Stocknews Com ,